|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||
| Due from related party | ||||||||||
| Cash | ||||||||||
| Restricted cash - held in trust account | ||||||||||
| Prepaid expenses | ||||||||||
| Total current assets | ||||||||||
| Marketable securities held in trust account | ||||||||||
| Other assets | ||||||||||
| Deferred offering costs | ||||||||||
| Marketable securities held in trust account | ||||||||||
| Total assets | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | ||||||||||
| Over-allotment liability | ||||||||||
| Accrued offering costs | ||||||||||
| Accounts payable and accrued expenses | ||||||||||
| Due to related party | ||||||||||
| Related Party | ||||||||||
| Total due to related party | ||||||||||
| Promissory note — related party | ||||||||||
| Class A common stock pending redemption (1,708,386 shares and no shares as of June 30, 2025 and December 31, 2024, respectively) | ||||||||||
| Convertible note - related party | ||||||||||
| Promissory note - related party | ||||||||||
| Deferred credit - operating expenses funded by potential target | ||||||||||
| Deferred credit - operating expenses funded by Xiaoyu Dida | ||||||||||
| Excise tax liability | ||||||||||
| Income taxes payable | ||||||||||
| Total current liabilities | ||||||||||
| Deferred underwriting fee payable | ||||||||||
| Deferred underwriting fee payable | ||||||||||
| Total liabilities | ||||||||||
| Class A common stock subject to possible redemption, $0.0001 par value; 26,000,000 shares authorized; 960,307 shares issued and outstanding and 2,668,693 shares issued and outstanding (at $11.55 and $11.25 redemption value as of June 30, 2025 and December 31, 2024, respectively) | ||||||||||
| Class A Common Stock | ||||||||||
| Total class A common stock subject to possible redemption, $0.0001 par value; 26,000,000 shares authorized; 960,307 shares issued and outstanding and 2,668,693 shares issued and outstanding (at $11.55 and $11.25 redemption value as of June 30, 2025 and December 31, 2024, respectively) | ||||||||||
| Stockholders’ deficit | ||||||||||
| Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | ||||||||||
| Common stock, value | ||||||||||
| Class A Common Stock | ||||||||||
| Class B Common Stock | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Total stockholders’ deficit | ||||||||||
| Total liabilities, common stock subject to possible redemption, and stockholders’ deficit |
Loading...
